{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:07:20Z","timestamp":1790179640193,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jgar.2026.07.006","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:14:15Z","timestamp":1785341655000},"page":"409-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Applying pharmaceutical care concepts to address antimicrobial resistance in low- and middle-income countries with particular emphasis on tuberculosis"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8146-1553","authenticated-orcid":false,"given":"Kirstin","family":"Messner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4616-2534","authenticated-orcid":false,"given":"Anna","family":"Bollinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Knopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrg","family":"Utzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S.","family":"Allemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2026.07.006_bib0001","unstructured":"World Health Organization. Antimicrobial resistance 2021. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance (accessed 08.09.23)."},{"key":"10.1016\/j.jgar.2026.07.006_bib0002","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1473-3099(19)30572-9","article-title":"Antibiotic exposure among children younger than 5 years in low-income and middle-income countries: a cross-sectional study of nationally representative facility-based and household-based surveys","volume":"20","author":"Fink","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2026.07.006_bib0003","article-title":"Antimicrobial resistance and its drivers-a review","volume":"11","author":"Irfan","year":"2022","journal-title":"Antibiot Basel"},{"key":"10.1016\/j.jgar.2026.07.006_bib0004","unstructured":"World Health Organization. Global action plan on antimicrobial resistance 2016. https:\/\/www.who.int\/publications-detail-redirect\/9789241509763 (accessed 21.11.23)."},{"key":"10.1016\/j.jgar.2026.07.006_bib0005","unstructured":"Africa CDC Findings in AMR surveillance data across Africa to shape health policy reform. 2023. https:\/\/africacdc.org\/news-item\/findings-in-amr-surveillance-data-across-africa-to-shape-health-policy-reform\/ (accessed 14.11.23)."},{"key":"10.1016\/j.jgar.2026.07.006_bib0006","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3201\/eid1903.120998","article-title":"Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection","volume":"19","author":"O\u2019Donnell","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.jgar.2026.07.006_bib0007","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S1473-3099(21)00808-2","article-title":"25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward","volume":"22","author":"Dean","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2026.07.006_bib0008","unstructured":"World Health Organization. Global Tuberculosis Report 2025 2025. https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2025 (accessed 14.04.26)."},{"key":"10.1016\/j.jgar.2026.07.006_bib0009","unstructured":"World Health Organization. The end TB strategy 2015. https:\/\/www.who.int\/publications\/i\/item\/WHO-HTM-TB-2015.19 (accessed 10.09.24)."},{"key":"10.1016\/j.jgar.2026.07.006_bib0010","first-page":"1","article-title":"What is \u201cpharmaceutical care\u201d in 2013?","volume":"11","author":"van Mil","year":"2013","journal-title":"Pharm Pr"},{"key":"10.1016\/j.jgar.2026.07.006_bib0011","first-page":"1123","article-title":"Tuberculosis prevention: current strategies and future directions","volume":"30","author":"Vasiliu","year":"2024","journal-title":"Clin Microbiol Infect Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2026.07.006_bib0012","first-page":"287","article-title":"The effect of an educational intervention on awareness of various aspects of pulmonary tuberculosis in patients with the disease","volume":"27","author":"Yousif","year":"2021","journal-title":"East Mediterr Health J Rev Sante Mediterr Orient Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit"},{"key":"10.1016\/j.jgar.2026.07.006_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1234785","article-title":"The impact of the COVID-19 pandemic on the global tuberculosis epidemic","volume":"14","author":"Falzon","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jgar.2026.07.006_bib0014","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/tropicalmed8050287","article-title":"Practical models of pharmaceutical care for improving tuberculosis patient detection and treatment outcomes: a systematic scoping review","volume":"8","author":"Pradipta","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.jgar.2026.07.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.hlpt.2023.100806","article-title":"Current evidence on the use of mHealth approaches in sub-Saharan Africa: a scoping review","volume":"12","author":"Aboye","year":"2023","journal-title":"Health Policy Technol"},{"key":"10.1016\/j.jgar.2026.07.006_bib0016","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1080\/21645515.2018.1476814","article-title":"The role of vaccines in fighting antimicrobial resistance (AMR)","volume":"14","author":"Jansen","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jgar.2026.07.006_bib0017","first-page":"1","article-title":"Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Gu\u00e9rin vaccination against tuberculosis","volume":"17","author":"Abubakar","year":"2013","journal-title":"Health Technol Assess Winch Engl"},{"key":"10.1016\/j.jgar.2026.07.006_bib0018","article-title":"Tuberculosis: how close are we to a new vaccine?","volume":"387","author":"Mahase","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.jgar.2026.07.006_bib0019","year":"2020","journal-title":"WHO operational handbook on tuberculosis"},{"key":"10.1016\/j.jgar.2026.07.006_bib0020","article-title":"Adherence determination using urine-tenofovir point-of-care testing and pharmacy refill records: a cross-sectional study","volume":"102","author":"Herbertson","year":"2023","journal-title":"Med. (Baltim.)"},{"key":"10.1016\/j.jgar.2026.07.006_bib0021","unstructured":"Trustonic. What are the barriers to smartphone expansion across Africa? 2023. https:\/\/www.trustonic.com\/opinion\/what-are-the-barriers-to-smartphone-expansion-across-africa\/ (accessed 17.05.2024)."},{"key":"10.1016\/j.jgar.2026.07.006_bib0022","series-title":"Klinische Pharmazie","author":"Jaehde","year":"2017"},{"key":"10.1016\/j.jgar.2026.07.006_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00683-23","article-title":"Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis","volume":"67","author":"Stemkens","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.07.006_bib0025","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/cpt.2309","article-title":"Clinical Pharmacogenetics Implementation Consortium guideline for the use of aminoglycosides based on MT-RNR1 genotype","volume":"111","author":"McDermott","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jgar.2026.07.006_bib0026","unstructured":"National Institute for Health and Care Excellence. Genedrive MT-RNR1 id kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies: early value assessment. Nice guidance. 2023. https:\/\/www.nice.org.uk\/guidance\/hte6 (accessed 20.08.2024)."}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371652600113X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371652600113X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:51:22Z","timestamp":1790178682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371652600113X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S221371652600113X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2026.07.006","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applying pharmaceutical care concepts to address antimicrobial resistance in low- and middle-income countries with particular emphasis on tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2026.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}